NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Plotkin SA, Orenstein WA, editors. Vaccines. 3rd edition. Philadelphia: Saunders; 1999.

Cover of Vaccines

Vaccines. 3rd edition.

Show details

Table of Contents

  • INTRODUCTION

  • 1.

    A Short History of Vaccination

    Susan L. Plotkin and Stanley A. Plotkin

    2.

    The History of Polio Vaccine Development

    Frederick C. Robbins

    3.

    The Immunology of Vaccination

    Gordon Ada

    4.

    Overview of Vaccine Manufacturing and Quality Assurance

    Gary B. Ebbert, Eugene D. Mascolo and Howard R. Six

    5.

    General Immunization Practices

    John C. Watson and Georges Peter

    6.

    Smallpox and Vaccinia

    Donald A. Henderson and Bernard Moss.

    7.

    Immunization in the Immunocompromised Host

    Per Ljungman

  • LICENSED VACCINES

  • 8.

    Bacille Calmette-Guérin Vaccine

    Kim Connelly Smith and Jeffrey R. Starke

    9.

    Diphtheria Toxoid

    Edward A. Mortimer Jr. and Melinda Wharton

    10.

    Hepatitis B Vaccine

    Francis J. Mahoney and Mark Kane

    11.

    Haemophilus influenzae Vaccines

    Joel I. Ward and Kenneth M. Zangwill

    12.

    Measles Vaccine

    Stephen C. Redd, Lauri E. Markowitz and Samuel L. Katz

    13.

    Mumps Vaccine

    Stanley A. Plotkin and Melinda Wharton

    14.

    Pertussis Vaccine

    Kathryn M. Edwards, Michael D. Decker and Edward A. Mortimer Jr.

    15.

    Inactivated Polio Vaccine

    Stanley A. Plotkin, Andrew D. Murdin and Emmanuel Vidor

    16.

    Live Attenuated Poliovirus Vaccines

    Roland W. Sutter, Stephen L. Cochi and Joseph L. Melnick

    17.

    Rubella Vaccine

    Stanley A. Plotkin

    18.

    Tetanus Toxoid

    Steven G. F. Wassilak , Walter A. Orenstein and Roland W. Sutter

    19.

    Varicella Vaccine

    Anne A. Gershon, Michiaki Takahashi and C. Jo White

    20.

    Combination Vaccines

    Michael D. Decker and Kathryn M. Edwards

  • VACCINES RECOMMENDED FOR ADULTS

  • 21.

    Inactivated Influenza Vaccines

    Edwin D. Kilbourne and Nancy H. Arden

    22.

    Pneumococcal Vaccine

    David S. Fedson, Daniel M. Musher and Juhani Eskola

  • VACCINES FOR SPECIAL RISK GROUPS AND SELECTED GEOGRAPHICAL AREAS

  • 23.

    Adenovirus Vaccines

    Charlotte A. Gaydos and Joel C. Gaydos

    24.

    Anthrax

    Philip S. Brachman and Arthur M. Friedlander

    25.

    Cholera Vaccines

    David A. Sack and Michel Cadoz

    26.

    Hepatitis A Vaccine

    Stephen M. Feinstone and Ian D. Gust

    27.

    Japanese Encephalitis Vaccines

    Theodore F. Tsai, Gwong-Jen J. Chang and Yong Xin Yu

    28.

    Meningococcal Vaccines

    Martha L. Lepow, Bradley A. Perkins, Patricia A. Hughes and Jan T. Poolman

    29.

    Miscellaneous Limited-Use Vaccines

    George R. French and Stanley A. Plotkin

    30.

    Plague

    Richard W. Titball, Stephen Eley, Diane E. Williamson and David T. Dennis

    31.

    Rabies Vaccine

    Stanley A. Plotkin, Charles E. Rupprecht and Hilary Koprowski

    32.

    Tick-Borne Encephalitis Vaccine

    Noel P. Barrett, Friedrich Dorner and Stanley A. Plotkin

    33.

    Typhoid Fever Vaccines

    Myron M. Levine

    34.

    Yellow Fever

    Thomas P. Monath

  • SELECTED VACCINES OF THE FUTURE

  • 35.

    New Technologies for Making Vaccines

    Ronald W. Ellis

    36.

    Cytomegalovirus Vaccines

    Stanley A. Plotkin

    37.

    Live Influenza Virus Vaccine

    Hunein F. Maassab, Louise M. Herlocher and Martin L. Bryant

    38.

    Human Immunodeficiency Virus

    Marc P. Girard and Jean-Louis Excler

    39.

    Lyme Disease Vaccine

    Janine Evans and Erol Fikrig

    40.

    Parasitic Disease Vaccines

    Peter J. Hotez

    41.

    Rotavirus Vaccines

    Fred H. Clark, Roger I. Glass and Paul A. Offit

  • PUBLIC HEALTH AND REGULATORY ISSUES

  • 42.

    Public Health Considerations - United States

    Walter A. Orenstein, Alan R. Hinman and Lance E. Rodewald

    43.

    Immunization in Europe

    David M. Salisbury and Sieghart Dittmann

    44.

    Vaccination Programs in Developing Countries

    Felicity T. Cutts and Jean-Marc Olivé

    45.

    Cost-Benefit and Cost-Effectiveness Analysis of Vaccine Policy

    Mark A. Miller and Alan R. Hinman

    46.

    Vaccines for International Travel

    Elizabeth Day Barnett, Robert T. Chen and Michel Rey

    47.

    Vaccines for Healthcare Workers

    David J. Weber, Kristen Weigle and William A. Rutala

    48.

    Regulation and Testing of Vaccines

    Paul D. Parkman and Carolyn M. Hardegree

    49.

    Safety of Vaccines

    Robert T. Chen

    50.

    U.S. Law

    Edmund W. Kitch, Geoffrey Evans and Robyn Gopin

  • EPILOGUE

  • Appendix 1. Recommendations of the Advisory Committee on Immunization Practices

  • Appendix 2. Immunobiologicals and Their Manufacturers and Distributors

  • Appendix 3. Representative Vaccine Information Statement (VIS)

  • Appendix 4. Case Definitions for Selected VaccinePreventable Diseases Under Public Health Surveillance in the United States

  • Copyright © 1999, W.B. Saunders Company.
    Bookshelf ID: NBK7297
    PubReader format: click here to try

    Views

    Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...